Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-006043

CEO sold 12,279 shares at $3.31 ($40,668)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-13 Sale : show line 1 in the form −12,279 $3.31 $40,668 1,052,045 D
Open-market sales · 12,279 sh · avg $3.31 · $40,668
Loading xslF345X05/form4.xml…